サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1393921

呼吸器診断の世界市場 (2024-2033年)：適応症・タイプ・検査タイプ・エンドユーザー・国 (16カ国超) 別の分析・予測

Global Respiratory Diagnostics Market: Focus on Disease Indication, Type, Test Type, End User, and Over 16 Countries' Data - Analysis and Forecast, 2024-2033
出版日: | 発行: BIS Research | ページ情報: 英文 159 Pages | 納期: 1～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
呼吸器診断の世界市場 (2024-2033年)：適応症・タイプ・検査タイプ・エンドユーザー・国 (16カ国超) 別の分析・予測
出版日: 2023年12月10日
発行: BIS Research
ページ情報: 英文 159 Pages
納期: 1～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の呼吸器診断の市場規模は、技術の進歩と疾病負担の増大に後押しされ、拡大すると予測されています。

当レポートでは、世界の呼吸器診断の市場を調査し、市場の背景・概要、市場成長への各種影響因子の分析、R&D・特許の動向、法規制環境、使用事例、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業の分析などをまとめています。

市場セグメンテーション

セグメンテーション1：適応症別

  • 結核
  • 喘息
  • 肺疾患
  • 慢性閉塞性肺疾患
  • その他

セグメンテーション2：エンドユーザー別

  • 病院・診療所
  • 診断ラボ
  • その他

セグメンテーション3：タイプ別

  • 機器・デバイス
  • アッセイ・試薬
  • サービス・ソフトウェア

セグメンテーション4：検査タイプ別

  • 機械的検査
  • OSA診断検査
  • 画像検査
  • 従来型診断検査
  • 分子診断検査

セグメンテーション5：地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

目次

第1章 市場

  • 動向：現在および将来の影響評価
  • サプライチェーンの概要
    • バリューチェーン分析
    • マーケットマップ
    • 原材料・部品の価格予測
  • R&Dレビュー
    • 特許出願動向 (国・企業別)
  • 規制状況
  • ステークホルダーの分析
    • 使用事例
  • 主要な世界的出来事の影響分析：COVID-19
  • 市場力学の概要
    • 市場促進要因
    • 市場抑制要因
    • 市場機会

第2章 用途

  • 用途の分類
  • 用途の概要
  • 世界の呼吸器診断市場 (適応症別)
    • 結核
    • 喘息
    • 肺癌
    • 慢性閉塞性肺疾患
    • その他
  • 世界の呼吸器診断市場 (エンドユーザー別)
    • 病院・診療所
    • 診断ラボ
    • その他

第3章 製品

  • 製品の分類
  • 製品概要
  • 世界の呼吸器診断市場 (製品別)
    • 市場概要
  • 世界の呼吸器診断市場 (タイプ別)
    • 機器・デバイス
    • アッセイ・試薬
    • サービス・ソフトウェア
  • 世界の呼吸器診断市場 (検査タイプ別)
    • 機械的試験
    • OSA診断テスト
    • 画像検査
    • 従来型診断テスト
    • 分子診断検査

第4章 地域

  • 地域概要
  • 推進因子・抑制因子
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第5章 市場：競合ベンチマーキング・企業プロファイル

  • 次のフロンティア
  • 地域的評価
    • Philips Healthcare
    • Beckton, Dickson & Company
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Dragerwerk AG & Co. KGaA
    • SDI Diagnostics
    • ResMed
    • Siemens Healthineers
    • PerkinElmer
    • Medtronic
    • GE Healthcare
    • Masimo Healthcare
    • Seegene, Inc.
    • Nihon Kohden Corporation

第6章 調査手法

図表

List of Figures

  • Figure 1: Region/country Largest Share of Market
  • Figure 2: Pricing/Cost Analysis by Region, Supply Chain
  • Figure 3: Global Respiratory Diagnostics Market, by Disease Indication, 2023, 2026 and 2033
  • Figure 4: Global Respiratory Diagnostics Market, by End User, 2023, 2026 and 2033
  • Figure 5: Global Respiratory Diagnostics Market, Global V/S Product Type
  • Figure 6: Global Respiratory Diagnostics Market, Global V/S Test Type
  • Figure 7: Key events to keep track of
  • Figure 8: Supply chain and Identifying Risks within the Supply Chain
  • Figure 9: January 2020-November 2023
  • Figure 10: January 2020-November 2023
  • Figure 11: Impact Analysis of Market Navigating Factors
  • Figure 12: Global Respiratory Diagnostics Market, 2002 and 2023
  • Figure 13: Global Respiratory Diagnostics Market, 2002 and 2023
  • Figure 14: U.S. Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 15: U.S. Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 16: U.S. Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 17: Canada Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 18: Canada Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 19: Canada Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 20: France Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 21: France Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 22: France Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 23: Germany Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 24: Germany Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 25: Germany Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 26: U.K. Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 27: U.K. Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 28: U.K. Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 29: Italy Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 30: Italy Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 31: Italy Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 32: Rest of Europe Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 33: Rest of Europe Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 34: Rest of Europe Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 35: China Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 36: China Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 37: China Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 38: India Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 39: India Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 40: India Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 41: Japan Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 42: Japan Respiratory Diagnostics Market, By Test End User ($ Million), 2022, 2026, and 2033
  • Figure 43: Japan Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 44: Rest-of-Asia-Pacific Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 45: Rest-of-Asia-Pacific Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 46: Rest-of-Asia-Pacific Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 47: The Middle East and Africa Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 48: The Middle East and Africa Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 49: The Middle East and Africa Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 50: The Middle East and Africa Respiratory Diagnostics Market, By Test Type ($ Million), 2023, 2026, and 2033
  • Figure 51: Latin America Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022, 2026, and 2033
  • Figure 52: Latin America Respiratory Diagnostics Market, By End User ($ Million), 2022, 2026, and 2033
  • Figure 53: Latin America Respiratory Diagnostics Market, By Type ($ Million), 2023, 2026, and 2033
  • Figure 54: Latin America Respiratory Diagnostics Market, By Test Type ($ Million), 2023, 2026, and 2033
  • Figure 55: Strategic Initiatives, 2020 - 2023
  • Figure 56: Share of Strategic Initiatives
  • Figure 57: Data Triangulation
  • Figure 58: Top-Down and Bottom-Up Approach
  • Figure 59: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Respiratory Diagnostics Market, Opportunities
  • Table 3: Global Respiratory Diagnostics Market, by Type $ Million, 2022-2033
  • Table 4: Global Respiratory Diagnostics Market, by Test Type, $ Million, 2022-2033
  • Table 5: Global Respiratory Diagnostics Market, By Region, ($ Million), 2022-2033
  • Table 6: North America Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 7: North America Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 8: North America Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 9: North America Respiratory Diagnostics Market, By Test Type ($ Million), 2022-2033
  • Table 10: U.S. Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 11: U.S. Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 12: U.S. Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 13: Canada Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 14: Canada Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 15: Canada Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 16: Europe Respiratory Diagnostics, By Disease Indication ($ Million), 2022-2033
  • Table 17: Europe Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 18: Europe Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 19: Europe Respiratory Diagnostics Market, By Test Type ($ Million), 2022-2033
  • Table 20: France Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 21: France Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 22: France Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 23: Germany Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 24: Germany Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 25: Germany Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 26: U.K. Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 27: U.K. Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 28: U.K. Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 29: Italy Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 30: Italy Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 31: Italy Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 32: Rest of Europe Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 33: Rest of Europe Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 34: Rest of Europe Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 35: Asia Pacific Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 36: Asia Pacific Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 37: Asia Pacific Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 38: Asia Pacific Respiratory Diagnostics Market, By Test Type ($ Million), 2022-2033
  • Table 39: China Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 40: China Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 41: China Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 42: India Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 43: India Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 44: India Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 45: Japan Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 46: Japan Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 47: Japan Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 48: Rest-of-Asia-Pacific Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 49: Rest-of-Asia-Pacific Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 50: Rest-of-Asia-Pacific Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 51: Rest-of-the-World Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 52: Rest-of-the-World Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 53: Rest-of-the-World Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 54: The Middle East and Africa Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 55: The Middle East and Africa Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 56: The Middle East and Africa Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 57: The Middle East and Africa Respiratory Diagnostics Market, By Test Type ($ Million), 2022-2033
  • Table 58: Latin America Respiratory Diagnostics Market, By Disease Indication ($ Million), 2022-2033
  • Table 59: Latin America Respiratory Diagnostics Market, By End User ($ Million), 2022-2033
  • Table 60: Latin America Respiratory Diagnostics Market, By Type ($ Million), 2022-2033
  • Table 61: Latin America Respiratory Diagnostics Market, By Test Type($ Million), 2022-2033
  • Table 62: Market Share
目次
Product Code: BHM1619SA

“Global Respiratory Diagnostics Market Set to Soar, Propelled by Technological Advancements and Growing Disease Burden.”

The respiratory diagnostics market is a rapidly growing focused on the diagnosis and monitoring of various respiratory conditions. It involves a wide range of novel technologies and devices that assist healthcare professionals in assessing and managing lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections.

The report provides a thorough examination of the respiratory diagnostics sector, delivering comprehensive insights into industry trends, technological progress, primary motivators, obstacles, and avenues for growth. Its goal is to furnish stakeholders, healthcare practitioners, scholars, and investors with a thorough comprehension of the present market status and future estimations within this swiftly evolving field. This comprehensive report addresses a broad array of respiratory diagnostic instruments and methodologies utilized in identifying, monitoring, and treating diverse respiratory ailments.

Market Segmentation:

Segmentation 1: by Disease Indication

  • Tuberculosis
  • Asthma
  • Lung Caner
  • Chronic Obstructive Pulmonary Disease
  • Others

Segmentation 2: by End Use

  • Hospitals and Clinics
  • Diagnostics Laboratory
  • Others

Segmentation 3: by Type

  • Instruments and Devices
  • Assays & Reagents
  • Services & Software

Segmentation 4: by Test Type

  • Mechanical Tests
  • OSA Diagnostic Test
  • Imaging Tests
  • Traditional Diagnostic Test
  • Molecular Diagnostic Tests

Segmentation 5: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest-of-the-World

Key Questions to be answered:

  • What are the focus areas of the global respiratory diagnostics market in the upcoming years?
  • What is the value of revenue generated from respiratory diagnostics market across the globe and at what rate is the demand expected to grow during the forecast period?
  • Which product(s) is poised to be the primary revenue generator in the global respiratory diagnostics market?
  • Among respiratory diagnostics segments, which is projected to capture the largest market share?
  • In terms of applications, which segment is forecasted to experience the highest Compound Annual Growth Rate (CAGR) during the forecast period?
  • Which end-user segment accounted for the largest share of the respiratory diagnostics market?
  • What are the key growth factors of this market? What are the major opportunities for existing market players and new entrants in the global respiratory diagnostics market? What are the major challenges faced by the existing players in the market?
  • Who are the major players dominating in the global respiratory diagnostics market space?
  • Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the respiratory diagnostics market for the forecast period?

Table of Contents

1 Markets

  • 1.1 Trends : Current and Future Impact Assessment
    • 1.1.1 Sample Text
    • 1.1.2 Trend 1
    • 1.1.3 Trend 2
    • 1.1.4 Trend 3
  • 1.2 Supply Chain Overview
    • 1.2.1 Value Chain Analysis
    • 1.2.2 Market Map
    • 1.2.3 Pricing Forecast for Raw Materials and Components
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Stakeholder Analysis
    • 1.5.1 Use case
  • 1.6 Impact Analysis for Key Global Events- Covid-19
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
    • 1.7.2 Market Restraints
    • 1.7.3 Market Opportunities

2 Application

  • 2.1 Application Segmentation
  • 2.2 Application Summary
  • 2.3 Global Respiratory Diagnostics Market (by Disease Indication)
    • 2.3.1 Tuberculosis
    • 2.3.2 Asthma
    • 2.3.3 Lung Caner
    • 2.3.4 Chronic Obstructive Pulmonary Disease
    • 2.3.5 Others
  • 2.4 Global Respiratory Diagnostics Market (by End Use)
    • 2.4.1 Hospitals and Clinics
    • 2.4.2 Diagnostics Laboratory
    • 2.4.3 Others

3 Products

  • 3.1 Product Segmentation
  • 3.2 Product Summary
  • 3.3 Global Respiratory Diagnostics Market - (by Product)
    • 3.3.1 Market Overview
      • 3.3.1.1 Analyst View
  • 3.4 Global Respiratory Diagnostics Market (by Type)
    • 3.4.1 Instruments and Devices
    • 3.4.2 Assays & Reagents
    • 3.4.3 Services & Software
  • 3.5 Global Respiratory Diagnostics Market, By Test Type
    • 3.5.1 Mechanical Tests
      • 3.5.1.1 Pulmonary Function Test
        • 3.5.1.1.1 Spirometry
        • 3.5.1.1.2 Peak Flow Test
        • 3.5.1.1.3 Others
    • 3.5.2 OSA Diagnostic Test
    • 3.5.3 Imaging Tests
      • 3.5.3.1 X-Ray
      • 3.5.3.2 Computed Tomography
      • 3.5.3.3 Magnetic Resonance Imaging (MRI)
      • 3.5.3.4 Positron Emission Tomography (PET)
      • 3.5.3.5 Other Imaging Tests
    • 3.5.4 Traditional Diagnostic Test
      • 3.5.4.1 Immunodiagnostics
      • 3.5.4.2 Biochemical Tests
      • 3.5.4.3 Microscopy
    • 3.5.5 Molecular Diagnostic Tests
      • 3.5.5.1 PCR
      • 3.5.5.2 Nucleic Acid Amplification Test
      • 3.5.5.3 In-situ Hybridization
      • 3.5.5.4 NGS
      • 3.5.5.5 Microarrays
      • 3.5.5.6 Others

4 Regions

  • 4.1 Regional Summary
  • 4.2 Drivers and Restraints as you go alone……
  • 4.3 North America
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 Application
    • 4.3.5 Product
    • 4.3.6 U.S.
    • 4.3.7 U.S. Respiratory Diagnostics Market by Application
    • 4.3.8 U.S. Respiratory Diagnostics Market by Product
    • 4.3.9 Canada
    • 4.3.10 Canada Respiratory Diagnostics Market by Application
    • 4.3.11 Canada Respiratory Diagnostics Market by Product
  • 4.4 Europe
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Application
    • 4.4.5 Product
    • 4.4.6 France
    • 4.4.7 France Respiratory Diagnostics Market by Application
    • 4.4.8 France Respiratory Diagnostics Market by Product
    • 4.4.9 Germany
    • 4.4.10 Germany Respiratory Diagnostics Market by Application
    • 4.4.11 Germany Respiratory Diagnostics Market by Product
    • 4.4.12 U.K.
    • 4.4.13 U.K. Respiratory Diagnostics Market by Application
    • 4.4.14 U.K. Respiratory Diagnostics Market by Product
    • 4.4.15 Italy
    • 4.4.16 Italy Respiratory Diagnostics Market by Application
    • 4.4.17 Italy Respiratory Diagnostics Market by Product
    • 4.4.18 Rest of Europe
    • 4.4.19 Rest of Europe Respiratory Diagnostics Market by Application
    • 4.4.20 Rest-of-Europe Respiratory Diagnostics Market by Product
  • 4.5 Asia Pacific
    • 4.5.1 Regional Overview
    • 4.5.2 Driving Factors for Market Growth
    • 4.5.3 Factors Challenging the Market
    • 4.5.4 Application
    • 4.5.5 Product
    • 4.5.6 China
    • 4.5.7 China Respiratory Diagnostics Market by Application
    • 4.5.8 China Respiratory Diagnostics Market by Product
    • 4.5.9 India
    • 4.5.10 India Respiratory Diagnostics Market by Application
    • 4.5.11 India Respiratory Diagnostics Market by Product
    • 4.5.12 Japan
    • 4.5.13 Japan Respiratory Diagnostics Market by Application
    • 4.5.14 Japan Respiratory Diagnostics Market by Product
    • 4.5.15 Rest-of-Asia-Pacific
    • 4.5.16 Rest-of-Asia-Pacific Respiratory Diagnostics Market by Application
    • 4.5.17 Rest-of-Asia-Pacific Respiratory Diagnostics Market by Product
  • 4.6 Rest-of-the-World
    • 4.6.1 Regional Overview
    • 4.6.2 Driving Factors for Market Growth
    • 4.6.3 Factors Challenging the Market
    • 4.6.4 Application
    • 4.6.5 Product
    • 4.6.6 The Middle East and Africa
    • 4.6.7 The Middle East and Africa Respiratory Diagnostics Market by Application
    • 4.6.8 The Middle East and Africa Respiratory Diagnostics Market by Product
    • 4.6.9 Latin America
    • 4.6.10 Latin America Respiratory Diagnostics Market by Application
    • 4.6.11 Latin America Respiratory Diagnostics Market by Product

5 Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Next Frontiers…..
  • 5.2 Geographic Assessment
    • 5.2.1 Philips Healthcare
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products / Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers
      • 5.2.1.5 Key Personnel
      • 5.2.1.6 Analyst View
      • 5.2.1.7 Market Share
    • 5.2.2 Beckton, Dickson & Company
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products / Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers
      • 5.2.2.5 Key Personnel
      • 5.2.2.6 Analyst View
      • 5.2.2.7 Market Share
    • 5.2.3 Thermo Fisher Scientific Inc.
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products / Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers
      • 5.2.3.5 Key Personnel
      • 5.2.3.6 Analyst View
      • 5.2.3.7 Market Share
    • 5.2.4 Abbott Laboratories
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products / Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers
      • 5.2.4.5 Key Personnel
      • 5.2.4.6 Analyst View
      • 5.2.4.7 Market Share
    • 5.2.5 Bio-Rad Laboratories, Inc.
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products / Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Target Customers
      • 5.2.5.5 Key Personnel
      • 5.2.5.6 Analyst View
      • 5.2.5.7 Market Share
    • 5.2.6 Dragerwerk AG & Co. KGaA
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products / Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers
      • 5.2.6.5 Key Personnel
      • 5.2.6.6 Analyst View
      • 5.2.6.7 Market Share
    • 5.2.7 SDI Diagnostics
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products / Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers
      • 5.2.7.5 Key Personnel
      • 5.2.7.6 Analyst View
      • 5.2.7.7 Market Share
    • 5.2.8 ResMed
      • 5.2.8.1 Overview
      • 5.2.8.2 Top Products / Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Target Customers
      • 5.2.8.5 Key Personnel
      • 5.2.8.6 Analyst View
      • 5.2.8.7 Market Share
    • 5.2.9 Siemens Healthineers
      • 5.2.9.1 Overview
      • 5.2.9.2 Top Products / Product Portfolio
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Target Customers
      • 5.2.9.5 Key Personnel
      • 5.2.9.6 Analyst View
      • 5.2.9.7 Market Share
    • 5.2.10 PerkinElmer
      • 5.2.10.1 Overview
      • 5.2.10.2 Top Products / Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Target Customers
      • 5.2.10.5 Key Personnel
      • 5.2.10.6 Analyst View
      • 5.2.10.7 Market Share
    • 5.2.11 Medtronic
      • 5.2.11.1 Overview
      • 5.2.11.2 Top Products / Product Portfolio
      • 5.2.11.3 Top Competitors
      • 5.2.11.4 Target Customers
      • 5.2.11.5 Key Personnel
      • 5.2.11.6 Analyst View
      • 5.2.11.7 Market Share
    • 5.2.12 GE Healthcare
      • 5.2.12.1 Overview
      • 5.2.12.2 Top Products / Product Portfolio
      • 5.2.12.3 Top Competitors
      • 5.2.12.4 Target Customers
      • 5.2.12.5 Key Personnel
      • 5.2.12.6 Analyst View
      • 5.2.12.7 Market Share
    • 5.2.13 Masimo Healthcare
      • 5.2.13.1 Overview
      • 5.2.13.2 Top Products / Product Portfolio
      • 5.2.13.3 Top Competitors
      • 5.2.13.4 Target Customers
      • 5.2.13.5 Key Personnel
      • 5.2.13.6 Analyst View
      • 5.2.13.7 Market Share
    • 5.2.14 Seegene, Inc.
      • 5.2.14.1 Overview
      • 5.2.14.2 Top Products / Product Portfolio
      • 5.2.14.3 Top Competitors
      • 5.2.14.4 Target Customers
      • 5.2.14.5 Key Personnel
      • 5.2.14.6 Analyst View
      • 5.2.14.7 Market Share
    • 5.2.15 Nihon Kohden Corporation
      • 5.2.15.1 Overview
      • 5.2.15.2 Top Products / Product Portfolio
      • 5.2.15.3 Top Competitors
      • 5.2.15.4 Target Customers
      • 5.2.15.5 Key Personnel
      • 5.2.15.6 Analyst View
      • 5.2.15.7 Market Share

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation
  • 6.2 Market Estimation and Forecast